Former US FDA Chief Counsels Offer Advice For Navigating Thorny First Amendment Conundrum
Executive Summary
Daniel Troy suggests FDA increase its investment in science of consumer understanding, while Richard Cooper recommends bully pulpit approach to get attention of industry; panel of former chief counsels stresses that agency cannot continue to ignore First Amendment issues.